Treatment of Streptococcal Pharyngitis
Penicillin or amoxicillin for 10 days is the treatment of choice for strep pharyngitis due to proven efficacy, narrow spectrum, safety, and low cost. 1
First-Line Treatment for Non-Allergic Patients
- Penicillin V or amoxicillin should be prescribed for 10 days to achieve maximal pharyngeal eradication of Group A Streptococcus and prevent acute rheumatic fever 1, 2
- Penicillin V 250 mg orally twice daily for 10 days is the standard regimen for children, while adults typically receive 500 mg twice daily 1, 3
- Amoxicillin is equally effective and more palatable, making it an excellent alternative to penicillin V 1, 4
- Intramuscular benzathine penicillin G should be used when compliance with oral therapy is questionable, particularly in populations where rheumatic fever remains prevalent 1, 5
Treatment for Penicillin-Allergic Patients
Non-Anaphylactic Penicillin Allergy
- First-generation cephalosporins (cephalexin 500 mg twice daily or cefadroxil 1 gram once daily for 10 days) are the preferred first-line alternatives for patients without immediate hypersensitivity reactions 1, 2
- Cross-reactivity risk with first-generation cephalosporins is only 0.1% in patients with non-immediate penicillin reactions 2
- Cephalexin 20 mg/kg per dose twice daily (maximum 500 mg/dose) for 10 days in children 2
Immediate/Anaphylactic Penicillin Allergy
All beta-lactam antibiotics must be avoided in patients with immediate hypersensitivity reactions (anaphylaxis, angioedema, respiratory distress, or urticaria within 1 hour) due to up to 10% cross-reactivity risk. 1, 2, 6
Clindamycin is the preferred choice for immediate/anaphylactic penicillin allergy:
- Adults: 300 mg orally three times daily for 10 days 2, 6
- Children: 7 mg/kg per dose three times daily (maximum 300 mg/dose) for 10 days 1, 2, 6
- Clindamycin has approximately 1% resistance rate among Group A Streptococcus in the United States 2, 6
- Demonstrates high efficacy even in chronic carriers 1, 6
Alternative macrolide options (use with caution due to resistance):
- Azithromycin: 12 mg/kg once daily (maximum 500 mg) for 5 days only 1, 2, 6
- Clarithromycin: 7.5 mg/kg per dose twice daily (maximum 250 mg/dose) for 10 days 1, 2, 6
- Macrolide resistance is 5-8% in the United States and varies geographically 2, 6
Critical Treatment Duration Requirements
- A full 10-day course is essential for all antibiotics except azithromycin to achieve maximal pharyngeal eradication and prevent acute rheumatic fever 1, 2, 5
- Azithromycin requires only 5 days due to its prolonged tissue half-life 1, 2, 7
- Shortening the course by even a few days results in appreciable increases in treatment failure rates 2
- Therapy can be safely postponed up to 9 days after symptom onset and still prevent acute rheumatic fever 2
Supportive Care and Adjunctive Therapy
For moderate to severe symptoms or high fever:
- Acetaminophen or NSAIDs (such as ibuprofen) should be considered as adjunctive therapy 1, 6
- Aspirin must be avoided in children due to Reye syndrome risk 1, 6
- Corticosteroids are not recommended 1, 6
Clinical Response Timeline
- Patients typically experience noticeable clinical improvement within 24-48 hours of starting antibiotics 5
- Patients are no longer contagious after 24 hours of appropriate antibiotic therapy 5
- Symptoms typically resolve within less than 1 week even without antibiotics, but antibiotics shorten duration by approximately 1-2 days 5
- Complete bacterial eradication requires the full treatment course despite early clinical improvement 5
Common Pitfalls to Avoid
- Do not use cephalosporins in patients with immediate/anaphylactic penicillin reactions due to 10% cross-reactivity risk 2, 6
- Do not prescribe azithromycin as first-line therapy - it should only be used when penicillin and preferred alternatives cannot be used 2
- Do not ignore local macrolide resistance patterns - resistance varies geographically and can lead to treatment failure 2, 6
- Do not shorten treatment courses below 10 days (except azithromycin's 5-day regimen) as this increases treatment failure and rheumatic fever risk 2, 5
- Do not routinely perform follow-up throat cultures in asymptomatic patients who have completed therapy 1, 5
Special Considerations
- Testing should only be considered in special circumstances such as patients with a history of rheumatic fever 5
- Chronic carriers generally do not require treatment as they are unlikely to spread infection or develop complications 1, 2
- For recurrent pharyngitis, consider that patients may be chronic carriers experiencing repeated viral infections rather than multiple true streptococcal infections 1